These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
135 related articles for article (PubMed ID: 34561284)
41. Community-acquired macrolide-resistant Mycoplasma pneumoniae pneumonia in patients more than 18 years of age. Miyashita N; Maruyama T; Kobayashi T; Kobayashi H; Taguchi O; Kawai Y; Yamaguchi T; Ouchi K; Oka M J Infect Chemother; 2011 Feb; 17(1):114-8. PubMed ID: 20676912 [TBL] [Abstract][Full Text] [Related]
42. Antibiotics for community acquired lower respiratory tract infections (LRTI) secondary to Mycoplasma pneumoniae in children. Gavranich JB; Chang AB Cochrane Database Syst Rev; 2005 Jul; (3):CD004875. PubMed ID: 16034954 [TBL] [Abstract][Full Text] [Related]
43. T-B cell epitope peptides induce protective immunity against Mycoplasma pneumoniae respiratory tract infection in BALB/c mice. Chen Y; Wu Y; Qin L; Yu L; Luo H; Li Y; Wang K; Chen L; Zhu C; He J; Zeng Y; Huang L; You X Immunobiology; 2021 May; 226(3):152077. PubMed ID: 33831654 [TBL] [Abstract][Full Text] [Related]
44. Chlamydia pneumoniae is an important cause of community-acquired pneumonia in school-aged children: serological results of a prospective, population-based study. Heiskanen-Kosma T; Korppi M; Laurila A; Jokinen C; Kleemola M; Saikku P Scand J Infect Dis; 1999; 31(3):255-9. PubMed ID: 10482053 [TBL] [Abstract][Full Text] [Related]
45. Chlamydia pneumoniae and Mycoplasma pneumoniae in young children from China with community-acquired pneumonia. Liu G; Talkington DF; Fields BS; Levine OS; Yang Y; Tondella ML Diagn Microbiol Infect Dis; 2005 May; 52(1):7-14. PubMed ID: 15878436 [TBL] [Abstract][Full Text] [Related]
46. Effect of Pneumococcal Conjugate Vaccine on the Natural Antibodies and Antibody Responses Against Protein Antigens From Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis in Children With Community-acquired Pneumonia. Andrade DC; Borges IC; Adrian PV; Meinke A; Barral A; Ruuskanen O; Käyhty H; Nascimento-Carvalho CM Pediatr Infect Dis J; 2016 Jun; 35(6):683-9. PubMed ID: 26954601 [TBL] [Abstract][Full Text] [Related]
47. Detection of Mycoplasma pneumoniae in adult community-acquired pneumonia by PCR and serology. Martínez MA; Ruiz M; Zunino E; Luchsinger V; Avendaño LF J Med Microbiol; 2008 Dec; 57(Pt 12):1491-1495. PubMed ID: 19018018 [TBL] [Abstract][Full Text] [Related]
48. Severe community-acquired pneumonia caused by macrolide-resistant Mycoplasma pneumoniae in a 6-year-old boy. Lung DC; Chan YH; Kwong L; Que TL Hong Kong Med J; 2011 Oct; 17(5):407-9. PubMed ID: 21979480 [TBL] [Abstract][Full Text] [Related]
49. Mycoplasma pneumoniae community-acquired pneumonia (CAP) in the elderly: Diagnostic significance of acute thrombocytosis. Cunha BA; Pherez FM Heart Lung; 2009; 38(5):444-9. PubMed ID: 19755196 [TBL] [Abstract][Full Text] [Related]
50. Detection of Mycoplasma pneumoniae in children with lower respiratory tract infections. Maheshwari M; Kumar S; Sethi GR; Bhalla P Trop Doct; 2011 Jan; 41(1):40-2. PubMed ID: 21123487 [TBL] [Abstract][Full Text] [Related]
51. Use of simple heuristics to target macrolide prescription in children with community-acquired pneumonia. Fischer JE; Steiner F; Zucol F; Berger C; Martignon L; Bossart W; Altwegg M; Nadal D Arch Pediatr Adolesc Med; 2002 Oct; 156(10):1005-8. PubMed ID: 12361446 [TBL] [Abstract][Full Text] [Related]
52. Serological and molecular detection of Mycoplasma pneumoniae in children with community-acquired lower respiratory tract infections. Kumar S; Garg IB; Sethi GR Diagn Microbiol Infect Dis; 2019 Sep; 95(1):5-9. PubMed ID: 31097260 [TBL] [Abstract][Full Text] [Related]
53. Comparison of polymerase chain reaction and the indirect particle agglutination antibody test for the diagnosis of Mycoplasma pneumoniae pneumonia in children during two outbreaks. Kim NH; Lee JA; Eun BW; Shin SH; Chung EH; Park KW; Choi EH; Lee HJ Pediatr Infect Dis J; 2007 Oct; 26(10):897-903. PubMed ID: 17901794 [TBL] [Abstract][Full Text] [Related]
54. Role of Chlamydia pneumoniae and Mycoplasma pneumoniae as causative agents of community-acquired pneumonia in hospitalised children and adolescents. Baer G; Engelcke G; Abele-Horn M; Schaad UB; Heininger U Eur J Clin Microbiol Infect Dis; 2003 Dec; 22(12):742-5. PubMed ID: 14610659 [TBL] [Abstract][Full Text] [Related]
55. Prevalence of Mycoplasma pneumoniae: a cause for community-acquired infection among pediatric populaztion. Chen FQ; Yang YZ; Yu LL; Bi CB Niger J Clin Pract; 2015; 18(3):354-8. PubMed ID: 25772918 [TBL] [Abstract][Full Text] [Related]
56. Genotyping and macrolide resistance of Mycoplasma pneumoniae identified in children with community-acquired pneumonia in Medellín, Colombia. Copete AR; Aguilar YA; Rueda ZV; Vélez LA Int J Infect Dis; 2018 Jan; 66():113-120. PubMed ID: 29155089 [TBL] [Abstract][Full Text] [Related]